» Articles » PMID: 27507337

Isolating and Purifying Clostridium Difficile Spores

Overview
Specialty Molecular Biology
Date 2016 Aug 11
PMID 27507337
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

The ability for the obligate anaerobe, Clostridium difficile to form a metabolically dormant spore is critical for the survival of this organism outside of the host. This spore form is resistant to a myriad of environmental stresses, including heat, desiccation, and exposure to disinfectants and antimicrobials. These intrinsic properties of spores allow C. difficile to survive long-term in an oxygenated environment, to be easily transmitted from host-to-host, and to persist within the host following antibiotic treatment. Because of the importance of the spore form to the C. difficile life cycle and treatment and prevention of C. difficile infection (CDI), the isolation and purification of spores are necessary to study the mechanisms of sporulation and germination, investigate spore properties and resistances, and for use in animal models of CDI. Here we provide basic protocols, in vitro growth conditions, and additional considerations for purifying C. difficile spores for a variety of downstream applications.

Citing Articles

Overcoming donor variability and risks associated with fecal microbiota transplants through bacteriophage-mediated treatments.

Rasmussen T, Mao X, Forster S, Larsen S, Von Munchow A, Tranaes K Microbiome. 2024; 12(1):119.

PMID: 38951925 PMC: 11218093. DOI: 10.1186/s40168-024-01820-1.


A conserved switch controls virulence, sporulation, and motility in C. difficile.

DiCandia M, Edwards A, Alcaraz Y, Monteiro M, Lee C, Vargas Cuebas G PLoS Pathog. 2024; 20(5):e1012224.

PMID: 38739653 PMC: 11115286. DOI: 10.1371/journal.ppat.1012224.


Robust and Transparent Silver Oxide Coating Fabricated at Room Temperature Kills Spores, MRSA, and .

Hosseini M, Huang J, Williams M, Gonzalez G, Jiang X, Falkinham 3rd J Microorganisms. 2024; 12(1).

PMID: 38257910 PMC: 10818310. DOI: 10.3390/microorganisms12010083.


An intravenous pancreatic cancer therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium novyi-Non Toxic.

Dailey K, Small J, Pullan J, Winfree S, Vance K, Orr M PLoS One. 2023; 18(11):e0289183.

PMID: 37963142 PMC: 10645340. DOI: 10.1371/journal.pone.0289183.


Glycine fermentation by promotes virulence and spore formation, and is induced by host cathelicidin.

Rizvi A, Vargas-Cuebas G, Edwards A, DiCandia M, Carter Z, Lee C Infect Immun. 2023; 91(10):e0031923.

PMID: 37754683 PMC: 10580938. DOI: 10.1128/iai.00319-23.


References
1.
Bouillaut L, McBride S, Sorg J . Genetic manipulation of Clostridium difficile. Curr Protoc Microbiol. 2011; Chapter 9:Unit 9A.2. PMC: 3615975. DOI: 10.1002/9780471729259.mc09a02s20. View

2.
Sorg J, Dineen S . Laboratory maintenance of Clostridium difficile. Curr Protoc Microbiol. 2009; Chapter 9:Unit9A.1. DOI: 10.1002/9780471729259.mc09a01s12. View

3.
Saujet L, Pereira F, Serrano M, Soutourina O, Monot M, Shelyakin P . Genome-wide analysis of cell type-specific gene transcription during spore formation in Clostridium difficile. PLoS Genet. 2013; 9(10):e1003756. PMC: 3789822. DOI: 10.1371/journal.pgen.1003756. View

4.
Francis M, Allen C, Sorg J . Spore Cortex Hydrolysis Precedes Dipicolinic Acid Release during Clostridium difficile Spore Germination. J Bacteriol. 2015; 197(14):2276-83. PMC: 4524186. DOI: 10.1128/JB.02575-14. View

5.
Burns D, Minton N . Sporulation studies in Clostridium difficile. J Microbiol Methods. 2011; 87(2):133-8. DOI: 10.1016/j.mimet.2011.07.017. View